Megestrol acetate in the management of advanced endometrial carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004357:Drug Synergism; D004717:Endometrium; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008535:Megestrol / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010386:Pelvic Neoplasms / Q000628:therapy; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000628:therapy; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology
D000970:Antineoplastic Agents; D008535:Megestrol